3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
70
Burkitt Lymphoma
17
Precursor Cell Lymphoblastic Leukemia-Lymphoma
16
Leukemia, Biphenotypic, Acute
14
Myelodysplastic Syndromes
12
Leukemia
9
Myeloproliferative Disorders
7
Lymphoma, Mantle-Cell
7
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
6
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
6
Sarcoma, Myeloid
4
Recurrence
4
Lymphoma, Non-Hodgkin
4
Lymphoma
4
Leukemia, Myelomonocytic, Chronic
4
Blast Crisis
4
Leukemia, Monocytic, Acute
3
Hematologic Neoplasms
3
Down Syndrome
3
Lymphoma, T-Cell
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Leukemia, Myelomonocytic, Juvenile
2
Leukemia, Myelomonocytic, Acute
2
Leukemia, Myeloid, Accelerated Phase
2
Leukemia, Myeloid
2
Hodgkin Disease
2
Anemia, Refractory, with Excess of Blasts
2
Thrombocythemia, Essential
1
Targeted Therapy
1
Interventions
glofitamab
2
Cyclophosphamide
2
pembrolizumab
1
obinutuzumab
1
fludarabine phosphate
1
Whole-Body Irradiation
1
Tacrolimus
1
Sirolimus
1
Peripheral Blood Stem Cell Transplantation
1
Oxaliplatin
1
Mycophenolic Acid
1
Methotrexate
1
Melphalan
1
Gemcitabine
1
Etoposide
1
Cyclosporine
1
Busulfan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Dendritic Cell Sarcoma, Interdigitating
×
Cytarabine
×
90 days
×
Clear all
No trials found.